- Home
- RGNX vs STK Comparison
RGNX vs STK Comparison
Compare RGNX & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- STK
- Stock Information
- Founded
- RGNX 2008
- STK 2009
- Country
- RGNX United States
- STK United States
- Employees
- RGNX N/A
- STK N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- STK Investment Managers
- Sector
- RGNX Health Care
- STK Finance
- Exchange
- RGNX Nasdaq
- STK Nasdaq
- Market Cap
- RGNX 387.0M
- STK 434.6M
- IPO Year
- RGNX 2015
- STK N/A
- Fundamental
- Price
- RGNX $8.85
- STK $28.33
- Analyst Decision
- RGNX Strong Buy
- STK
- Analyst Count
- RGNX 8
- STK 0
- Target Price
- RGNX $31.75
- STK N/A
- AVG Volume (30 Days)
- RGNX 1.3M
- STK 38.2K
- Earning Date
- RGNX 05-12-2025
- STK 01-01-0001
- Dividend Yield
- RGNX N/A
- STK 6.60%
- EPS Growth
- RGNX N/A
- STK N/A
- EPS
- RGNX N/A
- STK N/A
- Revenue
- RGNX $156,718,000.00
- STK N/A
- Revenue This Year
- RGNX $313.52
- STK N/A
- Revenue Next Year
- RGNX N/A
- STK N/A
- P/E Ratio
- RGNX N/A
- STK N/A
- Revenue Growth
- RGNX 80.70
- STK N/A
- 52 Week Low
- RGNX $5.04
- STK $24.95
- 52 Week High
- RGNX $15.36
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- RGNX 51.64
- STK 48.61
- Support Level
- RGNX $7.68
- STK $28.00
- Resistance Level
- RGNX $9.29
- STK $28.94
- Average True Range (ATR)
- RGNX 0.85
- STK 0.41
- MACD
- RGNX -0.08
- STK -0.10
- Stochastic Oscillator
- RGNX 43.42
- STK 16.92
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.